Citius Pharmaceuticals annual gross margin
2017
2018
Citius Pharmaceuticals Gross Margin Growth & History (CTXR)
Citius Pharmaceuticals's gross margin was 0.00% for fiscal 2018.
View full Citius Pharmaceuticals company overviewCitius Pharmaceuticals annual gross margin history
| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2018 | 2018-09-30 | 0.00% | 0.00 pp |
| 2017 | 2017-09-30 | 0.00% | — |
Citius Pharmaceuticals quarterly gross margin
Q1.26
Q2.26
Q3.26
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q3 2026 | 2026-06-30 | 67.07% | — |
| Q2 2026 | 2026-03-31 | 80.27% | — |
| Q1 2026 | 2025-12-31 | 79.99% | — |
Citius Pharmaceuticals gross margin trends
Between the periods ended 2017-09-30 and 2018-09-30, Citius Pharmaceuticals's gross margin increased from 0.00% to 0.00%, a change of 0.00 percentage points. The latest reported quarter, Q3 2026, shows 67.07%.
About the metric
What gross margin means
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
Calculation and source
How gross margin is calculated
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Citius Pharmaceuticals source filings ↗